Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ryo Shimoyama"'
Autor:
Ken Asada, Syuzo Kaneko, Ken Takasawa, Hidenori Machino, Satoshi Takahashi, Norio Shinkai, Ryo Shimoyama, Masaaki Komatsu, Ryuji Hamamoto
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
With the completion of the International Human Genome Project, we have entered what is known as the post-genome era, and efforts to apply genomic information to medicine have become more active. In particular, with the announcement of the Precision M
Externí odkaz:
https://doaj.org/article/9e8d2b92a68f4f3985b8878af56aedda
Autor:
Satoshi Takahashi, Ken Asada, Ken Takasawa, Ryo Shimoyama, Akira Sakai, Amina Bolatkan, Norio Shinkai, Kazuma Kobayashi, Masaaki Komatsu, Syuzo Kaneko, Jun Sese, Ryuji Hamamoto
Publikováno v:
Biomolecules, Vol 10, Iss 10, p 1460 (2020)
Mortality attributed to lung cancer accounts for a large fraction of cancer deaths worldwide. With increasing mortality figures, the accurate prediction of prognosis has become essential. In recent years, multi-omics analysis has emerged as a useful
Externí odkaz:
https://doaj.org/article/0dddb55258f14cc9a326e8e1809c1f3f
Autor:
Ryo Shimoyama, Kazuhiro Nishikawa, Motohiro Hirao, Michihiko Miyazaki, Atsushi Miyamoto, Naoki Hama, Shinya Kato, Masakazu Miyake, Kiyoshi Mori, Takeshi Kato, Takuya Hamakawa
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 54:490-496
Autor:
Shun Ichi Watanabe, Ryo Shimoyama, Masashi Wakabayashi, Hiroshige Yoshioka, Tomoko Kataoka, Tadayoshi Hashimoto, Satoshi Ishikura, Kazuo Nakagawa, Haruhiko Fukuda, Tomonari Sasaki
Publikováno v:
Japanese Journal of Clinical Oncology. 51:999-1003
The standard treatment for pathological N2 Stage III non-small cell lung cancer with negative surgical margins in Japan is cisplatin-based adjuvant chemotherapy. However, recent studies suggest that the addition of thoracic radiotherapy after adjuvan
Autor:
Ryo Shimoyama, Kenji Suzuki, Haruhiko Fukuda, Shun-ichi Watanabe, Hiroshi Katayama, Masashi Wakabayashi, Yasuhiro Tsutani
Publikováno v:
Japanese Journal of Clinical Oncology. 50:1209-1213
Anatomical segmentectomy or wedge resection is recommended for high-risk operable patients with clinical stage IA non-small cell lung cancer in guidelines of the National Comprehensive Cancer Network and the Japanese Lung Cancer Society. However, the
First report of natural hybridization between two yellowtails, Seriola quinqueradiata and S. lalandi
Publikováno v:
Ichthyological Research. 68:139-144
We report here the first case of natural hybridization between two yellowtails, Seriola quinqueradiata and Seriola lalandi, based on AFLP and mtDNA sequence data. Analysis of AFLP data using Bayesian model-based clustering methods revealed that 25 of
Autor:
Satoshi Takahashi, Norio Shinkai, Ryo Shimoyama, Kazuma Kobayashi, Ken Takasawa, Ken Asada, Hidenori Machino, Masayoshi Yamada, Ryuji Hamamoto, Akira Sakai, Amina Bolatkan, Masaaki Komatsu, Syuzo Kaneko
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 886, p 886 (2021)
Journal of Personalized Medicine, Vol 11, Iss 886, p 886 (2021)
The coronavirus disease 2019 (COVID-19) pandemic began at the end of December 2019, giving rise to a high rate of infections and causing COVID-19-associated deaths worldwide. It was first reported in Wuhan, China, and since then, not only global lead
Autor:
Shogo Nomura, Shota Omori, Hirotsugu Kenmotsu, Ryo Shimoyama, Toshiaki Takahashi, Yuichiro Ohe, Hideyuki Harada, Masahiko Ando, Haruhiko Fukuda, Tomoko Kataoka, Tomonori Mizutani, Satoshi Ishikura
Publikováno v:
Japanese journal of clinical oncology. 51(5)
Daily low-dose carboplatin plus concurrent thoracic radiotherapy is the standard treatment for elderly patients with unresectable clinical stage (c-Stage) III non-small cell lung cancer (NSCLC) in Japan. However, a phase I study by Omori et al. sugge
Autor:
Ryo Shimoyama, Nobumasa Mizuno, Hiroshi Katayama, Haruhiko Fukuda, Gakuto Ogawa, Narikazu Boku, Tomoko Kataoka, Yukihide Kanemitsu, Tetsuya Hamaguchi, Yoshitaka Honma, Nozomu Machida, Susumu Hijioka, Hepatobiliary, Masanori Terashima, Junji Furuse
Publikováno v:
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 20(6)
Everolimus is recognized as one of the standard drugs for the treatment of unresectable or recurrent gastroenteropancreatic neuroendocrine tumors (NET). However, recent evidence has suggested that addition of somatostatin analogs to everolimus may yi
Autor:
Masashi Wakabayashi, Tadashi Aoki, Hiroyuki Ito, Ryo Shimoyama, Kazuo Nakagawa, Kazuya Takamochi, Keiju Aokage, Kenji Suzuki, Jiro Okami, Aritoshi Hattori, Hiroshige Yoshioka, Haruhiko Fukuda, Shiono Satoshi, Tomonori Mizutani, Shun-ichi Watanabe, Morihito Okada, Hisashi Saji, Yasuhiro Tsutani
Publikováno v:
The Journal of thoracic and cardiovascular surgery. 161(4)
Objective We performed a validation study to confirm the prognostic importance of the presence of a ground-glass opacity component based on data of the Japan Clinical Oncology Group study, JCOG0201, which was a prospective observational study to pred